BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 28650485)

  • 21. Differentiation of IMR32 Neuroblastoma Is Accompanied by a Global Change in the Transcriptome.
    Stepchenko AG; Portseva TN; Ilyin YV; Georgieva SG; Pankratova EV
    Dokl Biochem Biophys; 2021 Mar; 497(1):90-94. PubMed ID: 33895922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
    Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
    Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
    Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
    Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
    Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
    Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA; Lazarova DL; Ross RA; Biedler JL
    Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
    de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
    Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice.
    Achour M; Le Gras S; Keime C; Parmentier F; Lejeune FX; Boutillier AL; Néri C; Davidson I; Merienne K
    Hum Mol Genet; 2015 Jun; 24(12):3481-96. PubMed ID: 25784504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brg1 modulates enhancer activation in mesoderm lineage commitment.
    Alexander JM; Hota SK; He D; Thomas S; Ho L; Pennacchio LA; Bruneau BG
    Development; 2015 Apr; 142(8):1418-30. PubMed ID: 25813539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquisition of neuron-like electrophysiological properties in neuroblastoma cells by controlled expression of NDM29 ncRNA.
    Gavazzo P; Vella S; Marchetti C; Nizzari M; Cancedda R; Pagano A
    J Neurochem; 2011 Dec; 119(5):989-1001. PubMed ID: 21933186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation.
    Cavazza A; Miccio A; Romano O; Petiti L; Malagoli Tagliazucchi G; Peano C; Severgnini M; Rizzi E; De Bellis G; Bicciato S; Mavilio F
    Stem Cell Reports; 2016 Apr; 6(4):618-632. PubMed ID: 27050947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural crest and mesoderm lineage-dependent gene expression in orofacial development.
    Bhattacherjee V; Mukhopadhyay P; Singh S; Johnson C; Philipose JT; Warner CP; Greene RM; Pisano MM
    Differentiation; 2007 Jun; 75(5):463-77. PubMed ID: 17286603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation.
    Parodi F; Carosio R; Ragusa M; Di Pietro C; Maugeri M; Barbagallo D; Sallustio F; Allemanni G; Pistillo MP; Casciano I; Forlani A; Schena FP; Purrello M; Romani M; Banelli B
    Biochim Biophys Acta; 2016 Dec; 1859(12):1502-1514. PubMed ID: 27751904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deconstruction of DNA methylation patterns during myogenesis reveals specific epigenetic events in the establishment of the skeletal muscle lineage.
    Carrió E; Díez-Villanueva A; Lois S; Mallona I; Cases I; Forn M; Peinado MA; Suelves M
    Stem Cells; 2015 Jun; 33(6):2025-36. PubMed ID: 25801824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phox2B mutations and the Delta-Notch pathway in neuroblastoma.
    van Limpt V; Chan A; Schramm A; Eggert A; Versteeg R
    Cancer Lett; 2005 Oct; 228(1-2):59-63. PubMed ID: 16084642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas.
    Yang H; Schramek D; Adam RC; Keyes BE; Wang P; Zheng D; Fuchs E
    Elife; 2015 Nov; 4():e10870. PubMed ID: 26590320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic state determines inflammatory sensing in neuroblastoma.
    Wolpaw AJ; Grossmann LD; Dessau JL; Dong MM; Aaron BJ; Brafford PA; Volgina D; Pascual-Pasto G; Rodriguez-Garcia A; Uzun Y; Arsenian-Henriksson M; Powell DJ; Bosse KR; Kossenkov A; Tan K; Hogarty MD; Maris JM; Dang CV
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35121657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
    Zhao Z; Ma X; Sung D; Li M; Kosti A; Lin G; Chen Y; Pertsemlidis A; Hsiao TH; Du L
    RNA Biol; 2015; 12(5):538-54. PubMed ID: 25760387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-204 mediates post-transcriptional down-regulation of PHOX2B gene expression in neuroblastoma cells.
    Bachetti T; Di Zanni E; Ravazzolo R; Ceccherini I
    Biochim Biophys Acta; 2015 Aug; 1849(8):1057-65. PubMed ID: 26145533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity.
    D'Amico S; Tempora P; Gragera P; Król K; Melaiu O; De Ioris MA; Locatelli F; Fruci D
    Front Immunol; 2023; 14():1268645. PubMed ID: 37849756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A negative feedback loop of transcription factors specifies alternative dendritic cell chromatin States.
    Bornstein C; Winter D; Barnett-Itzhaki Z; David E; Kadri S; Garber M; Amit I
    Mol Cell; 2014 Dec; 56(6):749-62. PubMed ID: 25453760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.